← Leaderboards
Peter Colosi
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Gene Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$164,199,916
- Gregory H Reaman · National Childhood Cancer Foundation$155,841,493
- Randall J Bateman · Washington University$122,781,098
- Eric Martin McDade · Washington University$94,632,845
- Ronald G Crystal · Weill Medical College Of Cornell Univ$82,649,124
- Robert B. Diasio · University Of Alabama At Birmingham$73,470,685
Research focus
Gene TherapyRetinalInheritedGene Transduction AgentImmunityEngineeringEvaluationDependovirusCollaborationsDiabetic RetinopathyCapsidGenesAnimal ModelCell TypeAdeno-Associated Viral VectorGene ExpressionBaseClinical TrialsGene MutationComplementDesignCystDegenerative DisorderGlaucoma
Grant awards (6)
Retinal Gene Therapy$1,022,735
ZIA · FY2012 · EY · contact PI
Retinal Gene Therapy$295,003
ZIA · FY2011 · EY · contact PI
Retinal Gene Therapy$249,731
ZIA · FY2010 · EY · contact PI
Retinal Gene Therapy$1,071,862
ZIA · FY2009 · EY · contact PI
Retinal Gene Therapy$743,929
Z01 · FY2008 · EY · contact PI
Retinal Gene Therapy$865,383
Z01 · FY2007 · EY · contact PI